Without ongoing behavioral intervention, old habits remain in place , undermining the potential added benefits of the drug
Despite the lack of conclusive long-term data, the management of weight should be a priority in obese patients with hypertension, given the promising results from recent studies
Lipid improvements appear partially mediated by weight loss and may involve direct effects on hepatic lipid metabolism
KFFs analysis of newly released Medicare Part D spending data from CMS shows that total gross Medicare spending on the three newest versions of these diabetes medications that have also been recently approved for weight loss Ozempic, Rybelsus, and Mounjaro has skyrocketed in recent years, rising from $57 million in 2018 to $5.7 billion in 2022 (Figure 1)
However, individual reactions and side effects may vary, and some people have reported hair shedding while on treatment
Investors including Bain Capital backed the company's thesis that next-generation multi-receptor agonists and oral small molecules could capture meaningful share from first-generation agents
